Literature DB >> 8832135

Distribution of marker-Y chromosome containing cells in different tissues of a Turner mosaic patient with mixed gonadal dysgenesis.

R Petrusevska1, U Beudt, D Schäfer, M Schneider, E Brude, C Leitner, K Heller, J Arnemann.   

Abstract

We here describe a 12-year-old girl with numerous Turner stigmata and virilized external genitalia. Chromosome analysis of PHA stimulated lymphocytes using different banding techniques revealed a 45,X/46,X,+mar Turner mosaicism with the prominent marker present in about 90% of the blood cells. A PCR-based analysis using a set of 9 STS from different regions of the human Y chromosome indicated the presence of Y chromosomal material with a deletion breakpoint most likely within deletion interval 6. Because of the risk of gonadoblastoma for Turner patients carrying Y chromosomal material, and clinical indications of functional testicular tissue, a gonadectomy in addition to surgical correction of the external genitalia was performed. The histological analysis of the gonads showed a mixture of testicular tissue and ovarian stroma, thus indicating mixed gonadal dysgenesis. Fibroblasts from skin and different parts of the gonads were cytogenetically analyzed and showed a variable distribution of the Y-derived marker between 4% in skin, 11-31% in gonadal tissue and up to 90% in peripheral lymphocytes.

Entities:  

Mesh:

Year:  1996        PMID: 8832135     DOI: 10.1111/j.1399-0004.1996.tb03784.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  2 in total

1.  Limitations of G-banding Karyotype Analysis with Peripheral Lymphocytes in Diagnosing Mixed Gonadal Dysgenesis.

Authors:  Ikuko Takahashi; Junko Miyamoto; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2006-08-02

2.  SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal Disorders of Sex Development (DSD) patients with a mosaic karyotype.

Authors:  Remko Hersmus; Hans Stoop; Erin Turbitt; J Wolter Oosterhuis; Stenvert Ls Drop; Andrew H Sinclair; Stefan J White; Leendert Hj Looijenga
Journal:  BMC Med Genet       Date:  2012-11-16       Impact factor: 2.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.